Mechanisms of Immunosurveillance for Lung Cancer

Completed

Conditions studied: Lung Cancer

In brief

The purpose of this research study is to investigate the differences in "natural killer (NK) blood cells, a type of white blood cell that fights infection in the body, among different types of patients that have lung surgery. The four different groups of patients are: * smokers with lung cancer * smokers without lung cancer * non-smokers with lung cancer * non-smokers without lung cancer.

Key facts

Study ID

NCT01710319

Run by

Washington University School of Medicine

People needed

119

Starts

2012-09-01

Expected to finish

2016-07-07

Last updated by the study team

2018-05-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age equal or greater to 18 years
• Ability to read and write in English
• Able to participate in the informed consent process

You may not qualify if…

• Known active hepatitis B, hepatitis C, or HIV/AIDs (found in medical record)
• Chemotherapy or radiation therapy within 3 months of enrollment
• Type 1 Diabetes Mellitus
• Rheumatoid arthritis, Lupus, Multiple Sclerosis, or any other autoimmune disease as deemed necessary for exclusion by the Principal Investigator
• Previous organ transplant
• Blood transfusion within 3 months prior to enrollment
• Any previous cancer, excluding a previous lung cancer
• Steroid use within 4 weeks of enrollment

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.